Literature DB >> 34359899

Modeling Hepatotropic Viral Infections: Cells vs. Animals.

Niloofar Khoshdel-Rad1,2, Ensieh Zahmatkesh1,2, Polina Bikmulina3,4, Maria Peshkova3,4, Nastasia Kosheleva4,5, Evgeny A Bezrukov6, Roman B Sukhanov6, Anna Solovieva7, Anastasia Shpichka3,4,8, Peter Timashev3,4,7,8, Massoud Vosough1,2.   

Abstract

The lack of an appropriate platform for a better understanding of the molecular basis of hepatitis viruses and the absence of reliable models to identify novel therapeutic agents for a targeted treatment are the two major obstacles for launching efficient clinical protocols in different types of viral hepatitis. Viruses are obligate intracellular parasites, and the development of model systems for efficient viral replication is necessary for basic and applied studies. Viral hepatitis is a major health issue and a leading cause of morbidity and mortality. Despite the extensive efforts that have been made on fundamental and translational research, traditional models are not effective in representing this viral infection in a laboratory. In this review, we discuss in vitro cell-based models and in vivo animal models, with their strengths and weaknesses. In addition, the most important findings that have been retrieved from each model are described.

Entities:  

Keywords:  animal models; cell culture; hepatitis; hepatotropic virus

Year:  2021        PMID: 34359899     DOI: 10.3390/cells10071726

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  1 in total

Review 1.  Can next-generation humanized mice that reconstituted with both functional human immune system and hepatocytes model the progression of viral hepatitis to hepatocarcinogenesis?

Authors:  Jinglong Guo; Siyue Wang; Qi Gao
Journal:  Front Med (Lausanne)       Date:  2022-09-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.